Jan 13, 2021 / 12:30PM GMT
Christopher Thomas Schott - JPMorgan Chase & Co, Research Division - Senior Analyst
Good morning, everybody. I'm Chris Schott at JPMorgan, and very pleased to be introducing Pacira today to kick off day 3 of the JPMorgan Healthcare Conference. From the company, we have Dave Stack, the company's Chairman and CEO; as well as Charlie Reinhart, the company's CFO. As a reminder, we're going to have a -- Dave is going to make a presentation. From there, we're going to turn it over to a Q&A session. (Operator Instructions)
So with that, let me turn the presentation over to Dave, and we'll go to the Q&A after that.
David M. Stack - Pacira BioSciences, Inc. - Chairman & CEO
Thank you, Chris, and good morning, everyone, and the typical disclosures as well as our thank you to JPMorgan for making it possible for us to spend a few minutes with you this morning. We are in an exciting time at Pacira. We continue to grow the company around our 3 growth pillars. What I'd like to highlight to start out the program is that our mission is consistent, to
Pacira Biosciences Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot